E-resources
PDF-
Wijburg, Frits A; Węgrzyn, Grzegorz; Burton, Barbara K; Tylki-Szymańska, Anna
Acta Paediatrica, 20/May , Volume: 102, Issue: 5Journal Article
Mucopolysaccharidosis III is a rare genetic disease characterized by progressive cognitive decline and severe hyperactivity that does not respond to stimulants. Somatic features are relatively mild. Patients are often initially misdiagnosed as having idiopathic developmental delay, attention deficit/hyperactivity disorder and/or autism spectrum disorders, putting them at risk for unnecessary testing and treatments. Conclusion Children with developmental or speech delay, especially those with a characteristic somatic feature or behavioural abnormalities, should be screened for MPS III.
